Dbouk Hashem A, Tawil Ayman, Nasr Fahd, Kandakarjian Loucine, Abou-Merhi Raghida
Department of Biology, Faculty of Sciences I, Lebanese University, Hadath, Lebanon.
Open Clin Cancer J. 2007 Nov 8;1:1-5. doi: 10.2174/1874189400701010001.
Carcinoembryonic antigen and vascular endothelial growth factors are among the most important prognostic markers of colorectal cancer. Testing for these markers independently has been of limited value in screening for this tumor. The aim of this study is to determine the importance of simultaneous blood CEA and VEGF level determinations in diagnosis of colorectal cancer. Thirty-six patients diagnosed with colorectal cancer along with eight healthy controls were tested by ELISA for CEA and VEGF levels in serum and plasma, respectively. The positive predictive value of these markers was 95.4% for CEA and 89.5% for VEGF, and for combined CEA and VEGF was also high at 88%. Combined CEA and VEGF blood level assay constitutes a useful panel in detecting patients with colorectal cancer. Positive results allow selection of a subgroup of patients with a high tumor risk; therefore, such tests comprise valuable tumor diagnostic tests to add to current detection methods.
癌胚抗原和血管内皮生长因子是结直肠癌最重要的预后标志物之一。单独检测这些标志物在该肿瘤的筛查中价值有限。本研究的目的是确定同时测定血液中癌胚抗原(CEA)和血管内皮生长因子(VEGF)水平在结直肠癌诊断中的重要性。对36例经诊断患有结直肠癌的患者以及8例健康对照者分别采用酶联免疫吸附测定法(ELISA)检测血清和血浆中的CEA和VEGF水平。这些标志物的阳性预测值,CEA为95.4%,VEGF为89.5%,CEA和VEGF联合检测时也较高,为88%。CEA和VEGF血液水平联合检测在检测结直肠癌患者方面构成了一个有用的检测组合。阳性结果有助于筛选出肿瘤风险高的患者亚组;因此,此类检测是现有检测方法之外有价值的肿瘤诊断检测手段。